The Histolog Scanner is used for the rapid visualisation of fresh tissue microstructures. Credit: SamanTree Medical / Business Wire.

SamanTree Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Histolog Scanner, a device that enables high-resolution imaging of fresh tissue surfaces in real-time.

This Swiss-made device provides detailed insights into the microstructure of tissues, aiding surgeons and pathologists during medical procedures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The Histolog Scanner’s capability for ultra-fast confocal microscopy allows for the immediate imaging of resected tissues, which is expected to enhance the efficiency of physicians.

By providing this information instantaneously, the device aims to assist in the decision-making process during surgical procedures.

With the FDA clearance secured, SamanTree Medical is now set to accelerate its market entry in the US.

SamanTree Medical executive chairman Dr Charles Carignan said: “We are thrilled to introduce the Histolog Scanner to the US market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This FDA clearance is a significant milestone for the company. The ability of the Histolog Scanner to produce real-time imaging of the internal microstructure of tissues provides surgeons and pathologists with immediate, actionable information.”

The company has already established a presence in Europe with a CE mark obtained for the Histolog Scanner in 2018.

In July 2024, SamanTree Medical secured $14m in funding to further the development and commercialisation of the Histolog Scanner in both Europe and the US.

The Series B funding round was spearheaded by Relyens Innovation Santé, advised by Turenne Capital, and saw contributions from new investors such as Mutuelles Impact, Wille Finance, Noshaq, and Wallonie Entreprendre Life Sciences. Existing investors Panakès Partners, BOM, and b2venture also participated.